Phytotherapeutic agents in the management of symptomatic benign prostatic hyperplasia
Fitzpatrick, J.M.; Lynch, T.H.
Urologic Clinics of North America 22(2): 407-412
1995
ISSN/ISBN: 0094-0143 PMID: 7539185 Document Number: 454877
Phytotherapeutic agents constitute a large part of the market for the pharmacological treatment of symptomatic BPH. At present, these agents are being used on an empirical basis with some success in relieving symptoms. They have not been shown to have any effect on objective indices. Several agents are presently undergoing randomized trials.
Document emailed within 1 workday
Related Documents
Wu, T.T.; Lee, Y.H.; Jiaan, B.P.; Huang, J.K. 1995: The efficacy of finasteride in the treatment of symptomatic benign prostatic hyperplasia Zhonghua Yi Xue Za Zhi 56(6): 399-403Shao, Q.; Song, J.; Guo, Y.-w.; Lu, W.-c.; Du, L.-d. 2005: Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia Zhonghua Nan Ke Xue 11(7): 505-507
Savage, S.J..; Spungen, A.M..; Galea, G.; Britanico, J.; Vapnek, J.M.. 1998: Combination medical therapy for symptomatic benign prostatic hyperplasia Canadian Journal of Urology 5(3): 578-584
Anwarul Islam, A.K.M.; Kashem, M.A.; Shameem, I.A.; Kibria, S.A.M.G. 2005: Efficacy of terazosin and finasteride in symptomatic benign prostatic hyperplasia: a comparative study Bangladesh Medical Research Council Bulletin 31(2): 54-61
Kletscher, B.A.; Oesterling, J.E. 1995: Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia Urologic Clinics of North America 22(2): 423-430
Jonas, U.; Melchior, H.; Rübben, H. 1998: Recommendations for billing alternative therapy of benign prostatic hyperplasia. Laser therapy of benign prostatic hyperplasia Der Urologe. Ausg. a 37(1): 110-111
Samkange, C.; Bhagat, K. 2000: Pharmacological management of benign prostatic hyperplasia Central African Journal of Medicine 46(8): 224-228
Zhang, X-Hua. 2008: Current clinical management strategies for benign prostatic hyperplasia Chinese Medical Journal 121(17): 1759-1760
Suardi, N.; Gallina, A.; Salonia, A.; Briganti, A.; Cestari, A.; Guazzoni, G.; Rigatti, P.; Montorsi, F. 2009: Open prostatectomy and the evolution of HoLEP in the management of benign prostatic hyperplasia Minerva Urologica e Nefrologica 61(3): 301-308
Rocchietta, S. 1977: Current phytotherapeutic agents in the treatment of prostatic diseases Minerva Medica 68(63): 4261-4264
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Palacio, A.; Hernández, C.; Marqués, A.; Prats, J.; Espinosa, F.J. 2004: Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report Archivos Espanoles de Urologia 57(4): 451-460
Brannen, G.E.; Coffey, D.S. 1977: Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia Cancer Treatment Reports 61(2): 211-216
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Abdul-Muhsin, H.M.; Jakob, N.J.; McLemore, R.M.; McAdams, S.B.; Humphreys, M.R. 2016: Infectious complications associated with the use of temporary prostatic urethral stents in patients with benign prostatic hyperplasia Canadian Journal of Urology 23(5): 8465-8470
Blanc, M.; Sacrini, A.; Avogadro, A.; Gattamorta, M.; Lazzerini, F.; Gattoni, F.; Cretti, F. 1998: Prostatic volume: suprapubic versus transrectal ultrasonography in the control of benign prostatic hyperplasia La Radiologia Medica 95(3): 182-187
Pretlow, T.G.; Whitehurst, G.B.; Pretlow, T.P.; Hunt, R.S.; Jacobs, J.M.; McKenzie, D.R.; McDaniel, H.G.; Hall, L.M.; Bradley, E.L. 1982: Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia Cancer Research 42(11): 4842-4848
Granados Loarca, E.A. 1999: Medical treatment of benign prostatic hyperplasia. The efficacy of finasteride depends on prostatic volume Archivos Espanoles de Urologia 52(3): 201-208
Biktimirov, R.G.; Martov, A.G.; Biktimirov, T.R.; Marapov, D.I.; Kaputovskij, A.A. 2018: Comparative study of extraperitoneoscopic adenomectomy and monopolar transurethral resection in surgical management of benign prostatic hyperplasia with prostate volume of 100180 cm3 Urologiia 2018(3): 88-91
Maygarden, S.J.; Strom, S.; Ware, J.L. 1992: Localization of epidermal growth factor receptor by immunohistochemical methods in human prostatic carcinoma, prostatic intraepithelial neoplasia, and benign hyperplasia Archives of Pathology and Laboratory Medicine 116(3): 269-273